CONCORD, NC -- June 17, 2024 -- InvestorsHub NewsWire -- Hydromer, Inc. (OTC: HYDI) (the "Company"), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce that it has passed the recertification audits for its ISO 13485 certifications.

With successful ISO 13485 recertification, Hydromer Inc. is equipped to continue serving the medical device industry with a proven quality management system, providing their clients the assurance of the highest quality service and solutions.

"Safety and quality are non-negotiable in the medical devices industry. Achieving this successful ISO recertification demonstrates Hydromer's continued dedication to operating as a world-class company, delivering only the highest quality solutions to our valuable customers," said Mike Torti, CEO.

Established in 1947, the International Organization for Standardization (ISO) provides organizations with guidelines to consistently achieve universally recognized standards. ISO's global experts have developed over 25,000 International Standards, covering almost all aspects of technology, management, and manufacturing. ISO 13485 is the medical industry's optimal medical device standard, ensuring all medical devices meet the proper regulatory compliance laws and customer needs. This certification is a valuable credential to keep professionals and customers safe in clinics, hospitals, and other medical settings. 

 

About Hydromer

Hydromer, Inc. is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer R&D and manufacturing services capabilities for a wide variety of applications. We are domiciled in Concord, NC. Our customers are located across the United States, Europe and Asia-Pacific. Our facilities are U.S. Food and Drug Administration (FDA), Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001 compliant. For over four decades, the Company has developed value-added solutions to serve businesses in domestic and international markets in a wide range of industries. We manage numerous global B2B services such as coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. We have successfully developed numerous proprietary formulations and hold many patents worldwide, including those with anti-microbial, anti-fog, anti-frost, condensation-controlling, hydrophilic, and thromboresistant coating applications.

 

Contact: Hydromer Inc.

Info@hydromer.com

800-326-5976

 

Forward-Looking Statements

 

This press release contains forward-looking statements that are based on Hydromer's current expectations, estimates, forecasts, and projections. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions, and other factors that are difficult to predict and could cause actual results to differ materially from those expressed or anticipated. We caution readers not to place undue reliance on these forward-looking statements. Hydromer undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

 

 

Hydromer (CE) (USOTC:HYDI)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Hydromer (CE).
Hydromer (CE) (USOTC:HYDI)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Hydromer (CE).